Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06110312Not ApplicableNot Yet Recruiting

International Study to Evaluate a Navigation Program for Older People With Cancer and Their Family Caregivers (EU NAVIGATE Study)

Role: collaborator

NCT06097936Unknown

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

Role: collaborator

NCT05019989Not ApplicableCompleted

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study

Role: collaborator

NCT04107753Not ApplicableCompleted

The Impact of Brief Motivational Counseling for Smoking Cessation in an Italian Emergency Department: a Randomized Controlled Trial

Role: collaborator

NCT00420862Phase 3Terminated

The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography

Role: collaborator

All 5 trials loaded